INTERNATIONAL PATENT: KANGSTEM BIOTECH CO., LTD., 주식회사 강스템바이오텍 FILES APPLICATION FOR "COMPOSITION FOR PREVENTING OR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME COMPRISING PRIMED MESENCHYMAL STEM CELLS AS ACTIVE INGREDIENT"

GENEVA, May 19 -- KANGSTEM BIOTECH CO., LTD. (17F, 512, Teheran-ro,Gangnam-gu,Seoul 06179), 주식회사 강스템바이오텍 (서울특별시강남구테헤란로 512, 17층) filed a patent application (PCT/KR2024/017560) for "COMPOSITION FOR PREVENTING OR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME COMPRISING PRIMED MESENCHYMAL STEM CELLS AS ACTIVE INGREDIENT" on Nov 07, 2024. With publication no. WO/2025/100974, the details related to the patent application was published on May 15, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the W...